Marquette General Cancer Center

 

CLOSED CLINICAL TRIALS -


2011

 

Study Name - Chronic Lymphocytic Leukemia

 

Study Description -
To study the presence of human marginal zone (MZ) B cell markers in chronic lymphocytic leukemias carrying unmutated variable heavy chain antibody genes.

 

 

 


 

 

2010

 

 


 

Study Name - NSABP B44 Beth

Study Description -
NSABP B44 BETH - A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab CIRG (TRIO) 011/NSABP B44-1/B020906.

 

 


 

Study Name - TAILOR X

Study Description -
Program for the Assessment of Clinical Cancer Tests (PACCT-1) Trial Assigning IndividuaLized Options for Treatment (TAILORx)

 

 


 

 

Study Name - NSABP FC4

Study Description -
NSABP PROTOCOL FC-4/CP13-0708:  A Randomized Phase II Clinical Trial Investigating Irinotecan Plus Cetuximab With or Without Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody (IMC-A12) for the Treatment of Patients with Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum that has Progressed on Oxaliplatin and Bevacizumab Given as First-Line Therapy.

 


 

 

Study Name - SWOG-S0421

Study Description -
Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo For Patients with Advanced Hormone Refractory Prostate Cancer.

 

 


 

 

Study Name - CoSoft

Study Description -
Investigating cognitive function for patients participating in the

SOFT trial in selected centers

 

 


 

 

Study Name - SOFT

Study Description -
SOFT - Suppression of Ovarian Function Trial, A Phase III CTSU Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer.

 

 


 

 

 

Study Name - SWOG - S0307

Study Description -
Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

 

 


 

 

 

Study Name - SWOG 9925 - Closed: 04/15/2010

Study Description -
Lung cancer specimen repository protocol, ancillary

 

 

 


 

 

Study Name - SWOG - S000B - Closed: 04/15/2010

 

Study Description -
Prevention of Cataract and Age-Related Macular Degeneration with Vitamin E and Selenium - SELECT Eye Endpoints (SEE), Phase III Ancillary to S0000-SELECT.

 

 


 

 

Study Name - NSABP B-42 - Closed: 04/15/2010

 

Study Description -
NSABP B-42 A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer.

 

 


 

 

Study Name - SWOG S0226 - Closed: 01/15/2010

 

Study Description -
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer

 

 


 

 

 

Study Name - NSABP LTS-01- Closed: 01/15/2010

 

Study Description -
NSABP LTS-01 - Patient Reported Outcomes in Long Term Survivors with Colon and Rectal Cancer.

 

 


 

 

2009

 

Study Name - Avastin Aries - Closed: 11/16/2009

 

 

Study Name - ECOG E5204 Closed: 5/13/2009

 

Study Description -
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation.

 


 

 

 

Study Name - NSABP R-04 Closed: 5/13/2009

 

Study Description -
A CLINICAL TRIAL COMPARING PREOPERATIVE RADIATION THERAPY AND CAPECITABINE WITH OR WITHOUT OXALIPLATIN WITH PREOPERATIVE RADIATION THERAPY AND CONTINUOUS INTRAVENOUS INFUSION OF 5-FLUOROURACIL WITH OR WITHOUT OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM

 

 


 

 

Study Name - VELCADE Closed: 5/13/09

 

Study Description -
VELCADE - i071-341-03 (IRRC #6016): Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV VELCADE with Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma Following at Least One Prior Therapy.

 


 

 

Study Name - NSABP C-10 - Closed: 5/13/09

 

Study Description -
A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients with Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor.

 


 

 

Study Name - VIRGO - Closed: 8/12/2009

 

AVF4349n

DNA REPOSITORY SUBSTUDY IN ASSOCIATION WITH STUDY AVF4349n

 

ARCHIVAL TISSUE COLLECTION SUBSTUDY IN ASSOCIATION WITH STUDY AVF4349N

 

Study Description -
VIRGO - An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer AVF4349N; Archival Tissue Collection Substudy in Association with Study AV4349N; DNA Repository Substudy in Association with Study AVF4349N

 

 


 

 

2008

RTOG 0413

Closed: 11-12-2008

RTOG 0522

Closed: 11-12-2008

RTOG 0415

Closed: 11-12-2008

RTOG 0617/NCCTG

Closed: 11-12-2008

RTOG 0517
Closed: 11-12-2008

NSABP-B36
Closed: 08-13-2008

SWOG-S0500
Closed: 08-13-2008

SWOG-S0221
Closed: 08-13-2008

SWOG-S0600
Closed: 07-02-2008

NSABP PROTOCOL BP-59
Closed: 06-11-2008

NSABP PROTOCOL B-41
Closed: 06-11-2008

NSABP B-40
Closed: 06-11-2008

NSABP B-37
Closed: 06-11-2008

Co-STAR
Closed: 03-03-2008

RTOG 0435
Closed: 03-03-2008

ATLAS
Closed: 03-03-2008

SWOG-9346
Closed: 01-10-2008

 

2007

SWOG S00008
Closed: 12-2007

SWOG S0000B
Closed: 12-2007

RFS 2000
Closed: 10-2007

RTOG 0424
Closed: 09-2007

RTOG 0126
Closed: 09-2007

RTOG 0214
Closed: 09-2007

NSABP B-38
Closed: 05-2007

RTOG S0412
Closed: 01-2007

SWOG S0124
Closed: 01-2007

SWOG S0438
Closed: 01-20-07